Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Performance of the automated multiplex PCR Unyvero implant and tissue infections system in the management of diabetic foot osteomyelitis.

Dunyach-Remy C, Carrere C, Marchandin H, Schuldiner S, Guedj AM, Cellier N, Cadière A, Lechiche C, Sotto A, Lavigne JP.

Future Microbiol. 2018 Nov 29. doi: 10.2217/fmb-2018-0213. [Epub ahead of print]

PMID:
30489144
2.

Exploring the Microbiota of Diabetic Foot Infections With Culturomics.

Jneid J, Cassir N, Schuldiner S, Jourdan N, Sotto A, Lavigne JP, La Scola B.

Front Cell Infect Microbiol. 2018 Aug 14;8:282. doi: 10.3389/fcimb.2018.00282. eCollection 2018.

3.

The ins and outs of vesicular monoamine transporters.

Yaffe D, Forrest LR, Schuldiner S.

J Gen Physiol. 2018 May 7;150(5):671-682. doi: 10.1085/jgp.201711980. Epub 2018 Apr 17. Review.

4.

The Escherichia coli effluxome.

Schuldiner S.

Res Microbiol. 2018 Sep - Oct;169(7-8):357-362. doi: 10.1016/j.resmic.2018.02.006. Epub 2018 Mar 21. Review.

PMID:
29574104
5.

Emulating proton-induced conformational changes in the vesicular monoamine transporter VMAT2 by mutagenesis.

Yaffe D, Vergara-Jaque A, Forrest LR, Schuldiner S.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7390-E7398. Epub 2016 Nov 7.

6.

Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers.

Dunyach-Remy C, Courtais-Coulon C, DeMattei C, Jourdan N, Schuldiner S, Sultan A, Carrière C, Alonso S, Sotto A, Lavigne JP.

Diabetes Metab. 2017 Apr;43(2):167-171. doi: 10.1016/j.diabet.2016.09.003. Epub 2016 Oct 5.

PMID:
27720361
7.

A Transporter Interactome Is Essential for the Acquisition of Antimicrobial Resistance to Antibiotics.

Shuster Y, Steiner-Mordoch S, Alon Cudkowicz N, Schuldiner S.

PLoS One. 2016 Apr 6;11(4):e0152917. doi: 10.1371/journal.pone.0152917. eCollection 2016.

8.

A liposomal method for evaluation of inhibitors of H(+)-coupled multidrug transporters.

Melchior DL, Brill S, Wright GE, Schuldiner S.

J Pharmacol Toxicol Methods. 2016 Jan-Feb;77:53-7. doi: 10.1016/j.vascn.2015.09.007. Epub 2015 Oct 20.

PMID:
26463179
9.

Specificity determinants in small multidrug transporters.

Brill S, Sade-Falk O, Elbaz-Alon Y, Schuldiner S.

J Mol Biol. 2015 Jan 30;427(2):468-77. doi: 10.1016/j.jmb.2014.11.015. Epub 2014 Dec 3.

PMID:
25479374
10.

Functionally important carboxyls in a bacterial homologue of the vesicular monoamine transporter (VMAT).

Yaffe D, Vergara-Jaque A, Shuster Y, Listov D, Meena S, Singh SK, Forrest LR, Schuldiner S.

J Biol Chem. 2014 Dec 5;289(49):34229-40. doi: 10.1074/jbc.M114.607366. Epub 2014 Oct 21.

11.

Competition as a way of life for H(+)-coupled antiporters.

Schuldiner S.

J Mol Biol. 2014 Jul 15;426(14):2539-46. doi: 10.1016/j.jmb.2014.05.020. Epub 2014 May 24. Review.

12.

Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE): a promising tool to diagnose bacterial infections in diabetic foot ulcers.

Dunyach-Remy C, Cadière A, Richard JL, Schuldiner S, Bayle S, Roig B, Sotto A, Lavigne JP.

Diabetes Metab. 2014 Dec;40(6):476-80. doi: 10.1016/j.diabet.2014.03.002. Epub 2014 Apr 21.

PMID:
24751989
13.

Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.

Ugolev Y, Segal T, Yaffe D, Gros Y, Schuldiner S.

J Biol Chem. 2013 Nov 8;288(45):32160-71. doi: 10.1074/jbc.M113.502971. Epub 2013 Sep 23.

14.

Topology determination of untagged membrane proteins.

Nasie I, Steiner-Mordoch S, Schuldiner S.

Methods Mol Biol. 2013;1033:121-30. doi: 10.1007/978-1-62703-487-6_8.

PMID:
23996174
15.

Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2.

Yaffe D, Radestock S, Shuster Y, Forrest LR, Schuldiner S.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):E1332-41. doi: 10.1073/pnas.1220497110. Epub 2013 Mar 25.

16.

New substrates on the block: clinically relevant resistances for EmrE and homologues.

Nasie I, Steiner-Mordoch S, Schuldiner S.

J Bacteriol. 2012 Dec;194(24):6766-70. doi: 10.1128/JB.01318-12. Epub 2012 Oct 5.

17.

Transforming a drug/H+ antiporter into a polyamine importer by a single mutation.

Brill S, Falk OS, Schuldiner S.

Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16894-9. doi: 10.1073/pnas.1211831109. Epub 2012 Oct 3.

18.

Undecided membrane proteins insert in random topologies. Up, down and sideways: it does not really matter.

Schuldiner S.

Trends Biochem Sci. 2012 Jun;37(6):215-9. doi: 10.1016/j.tibs.2012.02.006. Epub 2012 Mar 21.

19.

Management of diabetic foot ulcers with a TLC-NOSF wound dressing.

Richard JL, Martini J, Bonello Faraill MM, Bemba JM, Lepeut M, Truchetet F, Ehrler S, Schuldiner S, Sauvadet A, Bohbot S.

J Wound Care. 2012 Mar;21(3):142-7.

PMID:
22399083
20.

Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.

Richard JL, Almasri M, Schuldiner S.

Diabetologia. 2012 May;55(5):1258-64. doi: 10.1007/s00125-012-2507-3. Epub 2012 Feb 25. Review.

PMID:
22361982
21.

Distinguishing colonization from infection with Staphylococcus aureus in diabetic foot ulcers with miniaturized oligonucleotide arrays: a French multicenter study.

Sotto A, Richard JL, Messad N, Molinari N, Jourdan N, Schuldiner S, Sultan A, Carrière C, Canivet B, Landraud L, Lina G, Lavigne JP; French Study Group on the Diabetic Foot.

Diabetes Care. 2012 Mar;35(3):617-23. doi: 10.2337/dc11-1352. Epub 2012 Feb 1.

22.

Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.

Sotto A, Richard JL, Combescure C, Jourdan N, Schuldiner S, Bouziges N, Lavigne JP.

Diabetologia. 2010 Oct;53(10):2249-55. doi: 10.1007/s00125-010-1828-3. Epub 2010 Jun 23.

PMID:
20571753
23.

Expression of neurotransmitter transporters for structural and biochemical studies.

Elbaz Y, Danieli T, Kanner BI, Schuldiner S.

Protein Expr Purif. 2010 Oct;73(2):152-60. doi: 10.1016/j.pep.2010.06.001. Epub 2010 Jun 8.

24.

Topologically random insertion of EmrE supports a pathway for evolution of inverted repeats in ion-coupled transporters.

Nasie I, Steiner-Mordoch S, Gold A, Schuldiner S.

J Biol Chem. 2010 May 14;285(20):15234-44. doi: 10.1074/jbc.M110.108746. Epub 2010 Mar 22.

25.

[Antibiotics in the treatment of wounds in the diabetic foot].

Richard JL, Schuldiner S, Jourdan N.

Soins. 2010 Jan-Feb;(742):48-50. French. No abstract available.

PMID:
20201471
26.

Directed evolution reveals hidden properties of VMAT, a neurotransmitter transporter.

Gros Y, Schuldiner S.

J Biol Chem. 2010 Feb 12;285(7):5076-84. doi: 10.1074/jbc.M109.081216. Epub 2009 Dec 10.

27.

In vitro unfolding and refolding of the small multidrug transporter EmrE.

Miller D, Charalambous K, Rotem D, Schuldiner S, Curnow P, Booth PJ.

J Mol Biol. 2009 Nov 6;393(4):815-32. doi: 10.1016/j.jmb.2009.08.039. Epub 2009 Aug 21.

PMID:
19699749
28.

A coordinated network of transporters with overlapping specificities provides a robust survival strategy.

Tal N, Schuldiner S.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9051-6. doi: 10.1073/pnas.0902400106. Epub 2009 May 18.

29.

EmrE, a model for studying evolution and mechanism of ion-coupled transporters.

Schuldiner S.

Biochim Biophys Acta. 2009 May;1794(5):748-62. doi: 10.1016/j.bbapap.2008.12.018. Epub 2009 Jan 3. Review.

PMID:
19167526
30.

[Epidemiology of diabetic foot problems].

Richard JL, Schuldiner S.

Rev Med Interne. 2008 Sep;29 Suppl 2:S222-30. doi: 10.1016/S0248-8663(08)73949-3. Review. French.

PMID:
18822247
31.

Identification of a glycine motif required for packing in EmrE, a multidrug transporter from Escherichia coli.

Elbaz Y, Salomon T, Schuldiner S.

J Biol Chem. 2008 May 2;283(18):12276-83. doi: 10.1074/jbc.M710338200. Epub 2008 Mar 5.

32.

Expression and function of the rat vesicular monoamine transporter 2.

Adam Y, Edwards RH, Schuldiner S.

Am J Physiol Cell Physiol. 2008 Apr;294(4):C1004-11. doi: 10.1152/ajpcell.00348.2007. Epub 2008 Feb 20.

33.

Parallel topology of genetically fused EmrE homodimers.

Steiner-Mordoch S, Soskine M, Solomon D, Rotem D, Gold A, Yechieli M, Adam Y, Schuldiner S.

EMBO J. 2008 Jan 9;27(1):17-26. Epub 2007 Dec 6.

34.

The fast release of sticky protons: kinetics of substrate binding and proton release in a multidrug transporter.

Adam Y, Tayer N, Rotem D, Schreiber G, Schuldiner S.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):17989-94. Epub 2007 Nov 2.

35.

MAS solid-state NMR studies on the multidrug transporter EmrE.

Agarwal V, Fink U, Schuldiner S, Reif B.

Biochim Biophys Acta. 2007 Dec;1768(12):3036-43. Epub 2007 Oct 2.

36.

Controversy over EmrE structure.

Schuldiner S.

Science. 2007 Aug 10;317(5839):748-51; author reply 748-51. No abstract available.

PMID:
17690276
37.

When biochemistry meets structural biology: the cautionary tale of EmrE.

Schuldiner S.

Trends Biochem Sci. 2007 Jun;32(6):252-8. Epub 2007 Apr 23. Review. Erratum in: Trends Biochem Sci. 2007 Jul;32(7):300.

PMID:
17452106
38.

The Internet and the diabetic foot: quality of online information in French language.

Richard JL, Schuldiner S, Jourdan N, Daurès JP, Vannerau D, Rodier M, Lavit P.

Diabetes Metab. 2007 Jun;33(3):197-204. Epub 2007 Mar 7.

PMID:
17347012
39.

On parallel and antiparallel topology of a homodimeric multidrug transporter.

Soskine M, Mark S, Tayer N, Mizrachi R, Schuldiner S.

J Biol Chem. 2006 Nov 24;281(47):36205-12. Epub 2006 Sep 26.

40.

Structural biology: the ins and outs of drug transport.

Schuldiner S.

Nature. 2006 Sep 14;443(7108):156-7. No abstract available.

PMID:
16971936
41.

Identification of tyrosine residues critical for the function of an ion-coupled multidrug transporter.

Rotem D, Steiner-Mordoch S, Schuldiner S.

J Biol Chem. 2006 Jul 7;281(27):18715-22. Epub 2006 May 3.

42.

3D model of the Escherichia coli multidrug transporter MdfA reveals an essential membrane-embedded positive charge.

Sigal N, Vardy E, Molshanski-Mor S, Eitan A, Pilpel Y, Schuldiner S, Bibi E.

Biochemistry. 2005 Nov 15;44(45):14870-80.

PMID:
16274234
43.

Characterization of bacterial drug antiporters homologous to mammalian neurotransmitter transporters.

Vardy E, Steiner-Mordoch S, Schuldiner S.

J Bacteriol. 2005 Nov;187(21):7518-25.

44.

Exploring the binding domain of EmrE, the smallest multidrug transporter.

Sharoni M, Steiner-Mordoch S, Schuldiner S.

J Biol Chem. 2005 Sep 23;280(38):32849-55. Epub 2005 Jul 27.

45.

Substrate-induced tryptophan fluorescence changes in EmrE, the smallest ion-coupled multidrug transporter.

Elbaz Y, Tayer N, Steinfels E, Steiner-Mordoch S, Schuldiner S.

Biochemistry. 2005 May 17;44(19):7369-77.

PMID:
15882076
46.

Exploring the role of a unique carboxyl residue in EmrE by mass spectrometry.

Weinglass AB, Soskine M, Vazquez-Ibar JL, Whitelegge JP, Faull KF, Kaback HR, Schuldiner S.

J Biol Chem. 2005 Mar 4;280(9):7487-92. Epub 2004 Dec 28.

47.
48.

Structural conservation in the major facilitator superfamily as revealed by comparative modeling.

Vardy E, Arkin IT, Gottschalk KE, Kaback HR, Schuldiner S.

Protein Sci. 2004 Jul;13(7):1832-40.

49.

A structural model of EmrE, a multi-drug transporter from Escherichia coli.

Gottschalk KE, Soskine M, Schuldiner S, Kessler H.

Biophys J. 2004 Jun;86(6):3335-48.

50.

The membrane topology of EmrE - a small multidrug transporter from Escherichia coli.

Ninio S, Elbaz Y, Schuldiner S.

FEBS Lett. 2004 Mar 26;562(1-3):193-6.

Supplemental Content

Loading ...
Support Center